CXC chemokines and their cognate receptors have been implicated widely in cancer pathogenesis. In this study, we report a critical causal relationship between CXCR6 expression and tumorigenesis in the setting of human hepatocellular carcinoma (HCC).
Introduction
Hepatocellular carcinoma (HCC) ranks fifth in frequency worldwide among all malignancies and is the third leading cause of cancer mortality (1) . Although hepatectomy represents the most effective treatment to obtain long-term survival, over 70% of patients relapse within 5 years, and the overall survival for HCC patients remains poor (2) . As an orphan tumor in regard to translational research and therapeutic options, it is important to get a better understanding of the underlying mechanisms leading to tumor invasion and metastasis, and to develop prognostic and therapeutic strategies in this disease.
Diverse roles have been reported for chemokines and their receptors in tumor biology, including direct effects on cancer cells, such as proliferation and invasion, and indirect effects on regulating inflammation and immunity (3, 4) . The chemokines can be subdivided into four classes, the C-C, C-X-C, C, and C-X3-C chemokines, in which the C-X-C chemokine network is a unique group of cytokines and receptors known for their disparate manner in regulating inflammation and cancer (5) (6) (7) . Studies have indicated that only a few genes, among them chemokine-receptor genes, had a significant role in determining the metastatic destination of different tumors (8) .
Different tumor types have distinct chemokine-receptor expression profiles, with CXCR4 and CCR7 extensively investigated (3) . Notably, CXCR4 is widely expressed in at least 23 different cancer types including HCC, and associated with more aggressive disease and poorer patient prognosis (3, 9, 10) . The CXCL12-CXCR4 axis is therefore of particular importance in cancer metastasis, and currently represent the CXCR6 promotes HCC metastasis 5 top target for therapeutic intervention. Likewise, CCR7 is the second frequently expressed chemokine-receptor in tumor cells, where the CCL21-CCR7 axis is primarily responsible for lymph node and brain metastases (3, 11, 12) .
In HCC, various chemokines and their receptors may not play the same role as they do in other tumors. After scrutinizing ten C-C chemokine-receptors including CCR1 to 10, we and others have identified that CCR1 was the only one expressed constitutively in all the human hepatoma cell lines examined (13, 14) . RNA interference and animal HCC model further confirmed the contribution of CCL3/CCL5-CCR1 axis to HCC metastasis and progression (13, 14) . Apart form the C-C chemokine-receptors, other chemokine-receptors may also play a role during the malignant progression of this fetal disease. However, except for CXCR4, the expression patterns of C-X-C, C and C-X3-C chemokine-receptors on HCC cells and the associated biological and clinical significance remains largely unknown.
Herein, we showed that CXCR6 and its ligand CXCL16 were consistently expressed in all the 8 hepatoma cell lines. We further identified CXCR6 as an independent predictor for increased recurrence and poor survival in HCC patients. Down-regulation of CXCR6 resulted in reduced invasive activities, tumor formation and metastasis of hepatoma cells. Moreover, CXCR6 could lead to a pro-tumor microenvironment in vivo via producing pro-inflammatory cytokines. In addition, the combination of CXCR6 and neutrophils was a superior predictor for recurrence and survival to either marker used alone. CXCR6-CXCL16 axis in HCC aggressiveness (Fig. 1A) .
By analyzing 24 pairs of HCC samples ( Fig. 1B; Supplementary Fig. 1 ), we found that CXCR6 protein levels were low in peritumor liver tissue, relatively higher in corresponding HCC by 1.8-fold (P < 0.0001, vs. peritumor liver), and particularly higher in HCC with vascular invasion by 2.2-fold (P = 0.032, vs. tumors without vascular invasion). In contrast, no significant difference in CXCL16 protein levels was detected between HCC and paired peritumor liver tissue ( Supplementary Fig. 1 ).
To determine the association of CXCR6 expression in HCC with disease outcome,
TMAs from 240 HCC patients were examined by immunostaining (Fig. 1C) . We found that CXCR6 expression in peritumor liver tissue was week or minimal. In HCC, Table 4 ). There was a striking inverse association between CXCR6 intensity and recurrence-free survival (RFS) (P = 0.007), and to a less extent overall survival (OS) (P = 0.064) (Fig. 1D ). The median OS and RFS time for (Table 1; Supplementary Tables 5, 6 ). Thus, CXCR6 expression is a valuable predictor for recurrence and survival in HCC patients.
In peritumor liver, CXL16 constitutively showed moderate or strong intensity in both cytoplasm and nuclei, and in HCC, CXCL16 was positive in either cytoplasm or nuclei or both ( Supplementary Fig. 1A ). Based on the combined cytoplasm and nuclear intensities, patients were categorized into CXCL6 -low (n = 114) or -high (n = 126) groups. Supplementary Tables 5, 6 ).
CXCR6 Knockdown Inhibits HCC Cell Invasion in vitro.
Given CXCR6's clinical significance in HCC, we wondered whether silenced endogenous CXCR6 expression could exhibit biological effects on hepatoma cells. and cell cycle either (data not shown). Intriguingly, CXCL16, in its soluble form or trans-membrane full-length form, could prominently promote control SK-HEP-1 and HCCLM3 cell invasion, but not CXCR6-knockdown cells ( Fig. 2A-B) . Likewise, down-regulation of CXCL16 markedly inhibited invasive activity of hepatoma cells in vitro ( Supplementary Fig. 3A ). These results indicate that the contribution of CXCR6
on HCC cell invasion may be due to CXCR6-CXCL16 signaling and an autocrine loop of CXCL16 production.
CXCR6 Knockdown Promotes Membrane Translocation of Caveolin-1 and ȕ-Catenin, with p38 and GSK3ȕ Pathways Involved.
To elucidate the mechanistic roles of CXCR6, the effect of CXCR6 disruption on expression of adhesion/invasion-associated proteins was examined. We showed that caveolin-1 and ȕ-catenin were significantly up-regulated in CXCR6-knockdown cells compared to control cells, while CXCL16 stimulation substantially decreased caveolin-1 and ȕ-catenin expression in control cells but not CXCR6-knockdown cells (Fig. 2C) . Meanwhile, E-cadherin, N-cadherin, vimentin and plakoglobin were detected, but no significant change consequent on CXCR6-knockdown was shown ( Supplementary Fig. 4A ).
Further effort was taken to the effect of CXCR6-knockdown on the distribution of caveolin-1 and ȕ-catenin. Stable cell lines grown at high density were fractionated into membrane and nucleus. As shown in Fig. 2D , the membrane-localization of caveolin-1 and ȕ-catenin was obviously enhanced in CXCR6-knockdown cells, while Because p38 MAPK and GSK3ȕ have well-established role in modulating caveolin-1 and ȕ-catenin expression (17, 18) , we assumed that they may operate in CXCR6-CXCL16 signaling. We found that phosphorylation of p38 was markedly increased, while inactivation (i.e., phosphorylation) of GSK3ȕ was obvious, in CXCR6-knockdown cells (Fig. 3A) . Notably, CXCL16 stimulation repressed phosphorylation of p38 and GSK3ȕ in control cells, whereas no obvious changes were seen in CXCR6-knockdown cells (Fig. 3A) , showing a parallel expression pattern with caveolin-1/ȕ-catenin and indicating that these pathways contributed to CXCR6-knockdown mediated inhibition of hepatoma cell invasion. Indeed, a p38 inhibitor SB202190 augmented, while a GSK3ȕ inhibitor TDZD8 repressed, in vitro invasion of hepatoma cells (Fig. 3B ). There were no significant differences in the invasive activities between CXCR6-knockdown and control hepatoma cells, in the presence of SB202190 or TDZD8 (Fig. 3B) , further supporting that p38 and GSK3ȕ have a crucial role in CXCR6 mediated tumor promotion. Consistent with the results of in vitro invasion assay, Western blotting showed that SB202190 further amplified, while TDZD8 partly recovered, the down-regulation of caveolin-1 and ȕ-catenin induced by CXCL16 stimulation in hepatoma cells (Fig. 3C ). In contrast, Rac1, Rho1, Cdc42, ERK and Akt signaling showed no significant change after shCtl-HCCLM3 (58.6 ± 6.2/HPF; P = 0.011), respectively ( Fig. 4C-D) . These data indicate that CXCR6 mediated tumor promoting effect may partly be attributed to enlarged inflammatory and angiogenic responses.
Then, to investigate the impact of CXCR6-knockdown on lung metastasis of hepatoma cells, shR6-HCCLM3 and control cells were implanted subcutaneously into the flanks of different nude mice (n = 6 each group). Serial sections confirmed that the pulmonary metastatic rates and metastatic tumor clusters per mouse were 100% (6/6) and 128.3 ± 12.3 in shCtl-HCCLM3 group, but were 33% (2/6) (P = 0.014) and 39.5 ± 7.5 (P = 0.001) in shR6-HCCLM3 group, respectively ( Fig. 4E-F) . Importantly, the metastatic foci of shR6-HCCLM3 group were mainly grades I-II, whereas most of metastatic foci in the controls were grades III-IV (Fig. 4E-F ). analysis. ELISA assays confirmed that IL-6 and IL-8 concentrations were much lower in shR6-SK-HEP-1 (36% and 61% inhibition respectively) and shR6-HCCLM3 (42% and 37% inhibition respectively) cells than their relative control cells (Fig. 5B) .
CXCR6 Knockdown Shifts
Similarly, we observed a significant decrease of IL-6 and IL-8 levels in shL16 compared to shCtl hepatoma cells ( Supplementary Fig. 3D ).
To characterize functional properties of IL-6 and IL-8, specific stimulating or blocking experiments were done. The addition of exogenous IL-6 and IL-8 significantly rescued the inhibitory effects of CXCR6-knockdown on hepatoma cell invasion (Fig. 5C) . Consistently, blocking IL-6R or IL-8RA or IL-8RB activities and neutralizing IL-6 or IL-8 actions with specific antibodies markedly reversed the invasion of hepatoma cells enhanced by CXCL16 (Fig. 5D) . Interestingly, similar to the effect of CXCL16, IL-6 or IL-8 administration reduced the membrane accumulation of caveolin-1 and ȕ-catenin via p38 and GSK3ȕ pathways (Fig. 5E ),
while cell proliferation and cell cycle distribution were not affected (data not shown).
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Altogether, these pro-inflammatory cytokines, via modulating both tumor microenvironment and tumor cells, significantly contributed to the tumor promoting role of CXCR6.
Combination of CXCR6 and Neutrophil Levels Has Better Prognostic Value for

HCC.
We analyzed the densities of tumor-infiltrating CD66b+ neutrophils, CD68+ Multivariate analyses revealed intratumoral neutrophil density as an independent index for RFS but not OS (Table 1; Supplementary Tables 5, 6 ). Using the Tables 5, 6 ). Therefore, evaluation of both CXCR6 expression and neutrophil infiltration is a powerful predictor of prognosis, further supporting the findings of altered inflammatory infiltration in mice hepatoma model.
Discussion
In this study, we found that CXCR6 content was low in normal hepatocytes, down-regulation of CXCR6 led to severe suppression of tumor growth, inflammatory infiltration, angiogenesis and lung metastasis of hepatoma. To our knowledge, this is the first report that CXCR6 expression is critical for HCC invasion and metastasis.
In line with these findings, in prostate cancer, suppressed CXCR6 expression was associated with decreased invasive activities, tumor growth, and reduced expression of proangiogenic factors (21) (22) (23) . Similarly, CXCR6 expression identifies a discrete subpopulation of human melanoma cells with a highly aggressive stem cell phenotype (24) . However, contrasting conclusions also exited. CXCR6 showed no clinical relevance and prognostic significance, while high expression of CXCL16 correlated with better prognosis and down-regulation of CXCL16 promoted tumor migratory behavior in renal cell carcinoma (25) . Additionally, a study in colorectal caner highlighted that high CXCL16 expression correlated with a better patient prognosis (26) , while in our study HCC patients with high expression of CXCL16 were prone to suffer from increased recurrence and reduced survival. Our results also rule out that different or inverse roles of the two types of CXCL16, the trans-membrane and soluble forms, like that reported in renal cell carcinoma (25) , existed in HCC. In addition, we found constitutively high CXCL16 expression in peritumor liver tissue.
Given that constitutive CXCL16 expression has also been demonstrated in bone marrow and lung (23, 27) , the two most common metastatic sites of HCC next to the liver, CXCR6-CXCL16 axis mediated site-specific metastasis of HCC can be envisioned.
Our results suggested that CXCR6-CXCL16 signaling may affect hepatoma cell CXCR6 promotes HCC metastasis 19 invasion though regulating the membrane translocation of caveolin-1 and ȕ-catenin.
Evidence has indicated that caveolin-1 is a tumor suppressor and participates in Wnt-independent regulation of transcriptional activity of ȕ-catenin (17, 28) . In particular, caveolin-1 recruits ȕ-catenin to caveolae membranes for its link with E-cadherin and thus promoting cell adhesion (29) . Thus, caveolin-1-dependent regulation of ȕ-catenin might be the underlying mechanism for enhanced cell-cell adhesion and reduced tumor metastases resulting from CXCR6 knockdown. Moreover, the parallel dynamics of caveolin-1 expression/translocation and p38 activation prompted us to hypothesize that p38 may involve in the up-regulation of caveolin-1 expression, as previously described (17) . Meanwhile, we observed the dampened In conclusion, our results suggest that CXCR6 expression is an independent prognostic factor and associated with invasive growth, inflammatory recruitment and angiogenic activities of HCC. These events involve p38 and GSK3ȕ signaling, and 
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